We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+15.41%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$6.93B
AUM Growth
+$1.24B
(+22%)
Cap. Flow
+$454M
Cap. Flow
% of AUM
6.54%
Top 10 Holdings %
Top 10 Hldgs %
16.4%
Holding
1,110
New
146
Increased
497
Reduced
266
Closed
160
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVR
NVR
|
+$34.9M |
| 2 |
SBA Communications
SBAC
|
+$31.5M |
| 3 |
Lennox International
LII
|
+$29.1M |
| 4 |
McKesson
MCK
|
+$24.8M |
| 5 |
Cable One
CABO
|
+$23.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$55.8M |
| 2 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$52.7M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$42.5M |
| 4 |
Intuitive Surgical
ISRG
|
+$35.5M |
| 5 |
XLNX
Xilinx Inc
XLNX
|
+$33.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.87% |
| 2 | Financials | 16.58% |
| 3 | Consumer Discretionary | 13.8% |
| 4 | Industrials | 12.36% |
| 5 | Healthcare | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Nu Skin
NUS
$247M
| $10.4M | 0.15% |
218,054
+68,475
| +46% | +$4.15M |
|
177
Box
BOX
$4.02B
| $10.4M | 0.15% |
538,048
+140,978
| +36% | +$2.92M |
|
|
DERM
178
DELISTED
Dermira, Inc.
DERM
| $10.3M | 0.15% |
763,590
+310,551
| +69% | +$2.59M |
|
179
Herbalife
HLF
$1.23B
| $10.2M | 0.15% |
192,210
+42,400
| +28% | +$2.44M |
|
|
RTN
180
DELISTED
Raytheon Company
RTN
| $10.2M | 0.15% |
+55,750
| New | +$9.72M |
|
181
Electronic Arts
EA
$52.4B
| $10.1M | 0.15% |
99,551
+2,590
| +3% | +$246K |
|
|
GHDX
182
DELISTED
Genomic Health, Inc.
GHDX
| $10.1M | 0.15% |
144,137
+72,270
| +101% | +$5.36M |
|
183
Varonis Systems
VRNS
$5.25B
| $10.1M | 0.15% |
506,928
+131,010
| +35% | +$2.49M |
|
184
Primerica
PRI
$9.81B
| $10.1M | 0.15% |
82,335
+2,189
| +3% | +$252K |
|
185
Maximus
MMS
$3.14B
| $10M | 0.14% |
140,865
+22,640
| +19% | +$1.59M |
|
186
NETSCOUT
NTCT
$2.86B
| $9.8M | 0.14% |
349,022
+133,887
| +62% | +$3.56M |
|
|
GLUU
187
DELISTED
Glu Mobile Inc.
GLUU
| $9.67M | 0.14% |
883,547
+24,260
| +3% | +$228K |
|
188
ProPetro Holding
PUMP
$1.45B
| $9.54M | 0.14% |
423,453
+104,600
| +33% | +$1.87M |
|
189
Cabot Corp
CBT
$4.65B
| $9.53M | 0.14% |
228,847
-68,080
| -23% | -$3.06M |
|
190
Axalta
AXTA
$7.01B
| $9.5M | 0.14% |
376,830
-11,490
| -3% | -$296K |
|
191
Itron
ITRI
$3.73B
| $9.49M | 0.14% |
203,434
+26,120
| +15% | +$1.39M |
|
|
HDS
192
DELISTED
HD Supply Holdings, Inc.
HDS
| $9.46M | 0.14% |
218,150
+53,310
| +32% | +$2.22M |
|
193
Avient
AVNT
$3.45B
| $9.46M | 0.14% |
322,600
+143,987
| +81% | +$4.52M |
|
194
Eastman Chemical
EMN
$7.8B
| $9.37M | 0.14% |
123,517
+113,177
| +1,095% | +$9M |
|
195
AXIS Capital
AXS
$8.59B
| $9.36M | 0.14% |
170,901
+28,190
| +20% | +$1.56M |
|
196
Stepan Co
SCL
$1.31B
| $9.3M | 0.13% |
106,302
+21,540
| +25% | +$1.87M |
|
197
Halliburton
HAL
$27.9B
| $9.3M | 0.13% |
317,460
-93,080
| -23% | -$2.81M |
|
|
WCC
198
WESCO International
WCC
$16.2B
| $9.25M | 0.13% |
174,551
+53,503
| +44% | +$2.83M |
|
|
ALE
199
DELISTED
Allete
ALE
| $9.21M | 0.13% |
111,980
-8,160
| -7% | -$643K |
|
200
Huntsman Corp
HUN
$2.24B
| $9.19M | 0.13% |
408,705
+123,321
| +43% | +$2.78M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q1 2019 Portfolio in Review
As of Q1 2019, Jacobs Levy Equity Management held 1,110 positions worth $6.93B, up 22% from $5.69B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Jacobs Levy Equity Management deployed $454M of net new capital in Q1 2019, opening 146 new positions and adding to 497 existing holdings. Its largest new stake was AbbVie: 282,010 shares worth $22.7M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Wellcare Health Plans, Inc., an estimated $52.7M trimmed.
- Jacobs Levy Equity Management's largest Q1 2019 buy was AbbVie: 282,010 shares worth $22.7M.
- Jacobs Levy Equity Management added most to NVR in Q1 2019, an estimated $34.9M increase.
- Jacobs Levy Equity Management's biggest Q1 2019 reduction was Wellcare Health Plans, Inc., cutting an estimated $52.7M.
- Jacobs Levy Equity Management fully exited Celgene Corp in Q1 2019, selling an estimated $55.8M.
- Jacobs Levy Equity Management's ten largest holdings make up 16% of its $6.93B portfolio in Q1 2019.
- Jacobs Levy Equity Management opened 146 new positions and closed 160 in Q1 2019.
- Jacobs Levy Equity Management's portfolio value rose 22% quarter-over-quarter to $6.93B.
Based on Jacobs Levy Equity Management's 13F filing for Q1 2019, filed 14 May 2019.